
Bridge Formulation Private Limited
About Bridge Formulation Private Limited
Data last updated:
Bridge Formulation Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2010PTC041468. Its GSTIN is 09AALCA7273M1ZZ (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Abhyudaya Educational Private Limited. It is led by directors Nirmal Jyoti and Shailesh Chaubey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 8/2A – 4H Unchava Lodge Gilat Bazar, Varanasi, Uttar Pradesh, India – 221002.
As per the financials filed for FY 2025, the company reported a revenue of ₹69.56 Lakh, a growth of 121% compared to the previous year. For the same year it recorded a net profit of ₹85,235 (net margin 1.2%) and EBITDA of ₹1.46 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 10% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Bridge Formulation has one previous CIN (Corporate Identification Number): U74900UP2010PTC041468. The current CIN is U24100UP2010PTC041468, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100UP2010PTC041468 | Current |
| U74900UP2010PTC041468 | Previous |
Contact details
Bridge Formulation Private Limited's registered office is in Varanasi, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered AddressS – 8/2A – 4H Unchava Lodge Gilat Bazar, Varanasi, Uttar Pradesh, India – 221002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bridge Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bridge Formulation is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Bridge Formulation Private Limited, buy the company report.
Financials of Bridge Formulation Private Limited
FY 2025 filings availableBridge Formulation Private Limited reported revenue of ₹69.56 Lakh (up 121% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 121% growth in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹85,235 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bridge Formulation Private Limited, buy the company report.
Board of directors of Bridge Formulation Private Limited
Bridge Formulation has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmal Jyoti Also directs: Shashwat Manufacturing Private Limited | Director | 10 May 2013 | 13 Years 6 Months | Current |
| Shailesh Chaubey | Director | 03 Jun 2025 | 1 Years 5 Months | Current |
Auditor
Bridge Formulation Private Limited is audited by BISEN & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BISEN & ASSOCIATES | FY 2020 | 017192N |
Shareholding
The shareholding of Bridge Formulation Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bridge Formulation Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Feb 2026 | 101238004 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Bridge Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bridge Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bridge Formulation Private Limited has a workforce of 6 employees on its EPFO records as of Nov 2025, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 6 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Bridge Formulation Private Limited, buy the company report.
GST
Bridge Formulation has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AALCA7273M1ZZ | Uttar Pradesh | Active | 09 Nov 2017 |
To see the full GST registrations and return filing status of Bridge Formulation Private Limited, buy the company report.
Recent activity
Bridge Formulation Private Limited has 7 board changes on record since 2013: 3 appointments and 4 cessations. The latest: Pankaj Kumar Srivastava ceased to be Director on 07 Jun 2025.
Frequently asked questions
Bridge Formulation is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 July 2010 (16+ years old) and is registered under CIN U24100UP2010PTC041468.
Bridge Formulation has 2 current directors:
- Nirmal Jyoti - Director
- Shailesh Chaubey - Director
The latest financial statements of Bridge Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bridge Formulation is 09AALCA7273M1ZZ, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Bridge Formulation is U24100UP2010PTC041468. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bridge Formulation was incorporated on 27 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Pankaj Kumar Srivastava ceased to be Director on 07 Jun 2025. Shailesh Chaubey was appointed as Director on 03 Jun 2025. Shikha Singh ceased to be Director on 01 Jul 2024. Bridge Formulation has 7 board changes on record in total.
The registered office of Bridge Formulation is at S – 82A – 4H Unchava Lodge Gilat Bazar, Varanasi, Uttar Pradesh, India – 221002.
Bridge Formulation operates in the pharma industry, in the drug formulation and development segment.
Bridge Formulation has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.

